Position Summary
The Director of Regulatory Affairs will lead and execute global regulatory strategies supporting the development and approval of MBXβs clinical stage and early-stage programs, including regulatory filings (INDs and CTAs) in alignment with health authority expectations. Provide strategic regulatory leadership across the early development portfolio with a focus on obesity programs, ensuring proactive, scientifically grounded regulatory input from discovery through clinical advancement.
Key Responsibilities
- Provide regulatory leadership and integrate regulatory considerations from discovery through IND-enabling activities.
- Partner with R&D and Clinical teams to shape regulatory strategies for the obesity portfolio.
- Design and execute comprehensive global regulatory strategies and plans.
- Develop and maintain proactive risk assessment and mitigation plans with cross-functional teams.
- Communicate regulatory developments to project teams, leadership, and stakeholders.
- Lead the regulatory sub-team and serve as primary Regulatory Affairs representative on asset development teams.
- Expand therapeutic area knowledge to improve regulatory submission quality and messaging.
- Liaise with health authorities, including leading and managing FDA meetings.
- Contribute to continuous improvement of regulatory processes and strategies.
- Monitor and anticipate industry trends impacting regulatory and market access.
Qualifications
- 10+ years regulatory experience in life sciences/pharmaceuticals, especially early phase development (IND/CTA, Phase IβII design).
- Experience supporting clinical stage development (Phase 1β3 highly valuable).
- Experience leading IND/CTA submissions and FDA/EMA interactions.
- Experience leading cross-functional preparation for regulatory meetings.
- Deep expertise in drug development and senior-level leadership behaviors.
- Strong organization, attention to detail, judgment, and time management.
- Understanding of FDA and EMA requirements.
- Excellent written/verbal communication; collaborative and solutions-oriented.
Travel & Schedule
- Hybrid work; average of three on-site days/week in Burlington.
- Periodic travel for business needs and meetings (including Together Weeks quarterly).